secwatch.observer — SEC 8-K summary
======================================

Issuer:     Crinetics Pharmaceuticals, Inc. (CRNX)
CIK:        0001658247
Form:       8-K
Filed at:   2023-06-21T23:59:59+00:00
Accession:  0000950170-23-029176
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Crinetics shareholders elect directors, ratify auditor, and approve say-on-pay on annual basis
--------------------------------------------------------------------------------

- Elected three Class II directors: Caren Deardorf, Weston Nichols (Ph.D.), Stephanie Okey (M.S.) for 3-year terms.
- Ratified BDO USA as independent auditor for FY2023 with 48,326,036 votes for, 3,916 against.
- Advisory vote on executive compensation approved: 45,092,585 for, 1,192,212 against.
- Advisory vote on say-on-pay frequency favored annual votes (41,312,125 for 1-year); company will hold annual votes.
- Approximately 90% of outstanding shares (48,336,267) were present at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1658247/000095017023029176/0000950170-23-029176-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1658247/000095017023029176/crnx-20230616.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-029176

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer